{"schema":"https://ver.cy/schemas/card/1.0.0","id":"vr.tr.cefpiramide","code":"thing-q4921174","url":"https://ver.cy/models/thing/q4921174/","name":"cefpiramide","alternateNames":[],"kind":"thing","status":"published","version":"0.1.0-research.1","language":"en","classifiers":{"family":"Thing Registry","category":"Physical world and living systems","entryKind":"thing","plane":"PHY","domain":["PHY.MAT"],"industry":[],"navPath":"","tags":[],"facets":{}},"whatItIs":"Cefpiramide is a semisynthetic third-generation cephalosporin antibiotic that inhibits bacterial cell-wall synthesis and has activity against susceptible Gram-positive and Gram-negative bacteria, including Pseudomonas aeruginosa.","purpose":"Enable an agent to recognise cefpiramide, assess the identity and condition of a material sample, and determine which handling, testing or use decisions its evidence supports.","scope":{"in":["Cefpiramide molecular identity, stereochemistry and verified identifier mappings","Distinction between parent cefpiramide, its ionic forms and salt-containing samples","Sample assay, impurities, water content and grade","Physical properties and stability under recorded conditions","Cefpiramide-specific antibacterial measurements and their experimental context","Substance handling requirements and jurisdiction-specific identity records"],"out":["Finished injectable products, excipient recipes and packaging specifications","Patient diagnosis, antibiotic selection and dosing decisions","Manufacturing routes, production equipment and process validation","General cephalosporin class knowledge beyond inherited context","Bacterial species, resistance determinants and infection models themselves"],"boundaries":[]},"distinguishingFeatures":["Match the parent structure against PubChem CID 636405 and CAS 70797-11-4; the reported parent formula is C25H24N8O7S2. [PubChem](https://pubchem.ncbi.nlm.nih.gov/compound/Cefpiramide)","Require the cefpiramide-specific substituents at cephem positions 3 and 7 and the recorded stereochemistry; a cephalosporin scaffold or similar drug name alone is insufficient. [PubChem](https://pubchem.ncbi.nlm.nih.gov/compound/Cefpiramide)","Check counterions, charge and water content before treating a cefpiramide sodium sample as equivalent to a stated mass of parent cefpiramide; a separate sodium monograph exists. [Japanese Pharmacopoeia](https://jpdb.nihs.go.jp/jp14e/14data/Part-I/Cefpiramide_Sodium.pdf)","Require evidence of intact cefpiramide rather than accepting antibacterial activity or a nonspecific chromatographic signal as proof of identity."],"structure":{"bundles":[{"id":"cefpiramide-identity","name":"Cefpiramide identity","description":"Establish the exact molecule and distinguish its material forms.","layers":[{"id":"molecular-recognition","name":"Molecular recognition","description":"Resolve names to the complete cefpiramide structure.","findings":[{"id":"structure-and-identifier-agreement","name":"Structure and identifier agreement","description":"Recognition requires agreement between a verified reference structure, stereochemistry and identifier records.","questions":[{"text":"Which authoritative record establishes the complete cefpiramide structure and stereochemistry?","id":"structure-and-identifier-agreement-q01","kind":"definition"},{"text":"Do the sample's CAS, name and structural identifiers resolve to that same parent substance?","id":"structure-and-identifier-agreement-q02","kind":"provenance"}]}]},{"id":"parent-and-salt-boundary","name":"Parent and salt boundary","description":"Separate registry identity from the composition of a supplied material.","findings":[{"id":"explicit-material-form","name":"Explicit material form","description":"Represent a salt-containing or hydrated sample with its counterion and water basis before translating its content into cefpiramide equivalents.","questions":[{"text":"Does this sample contain parent cefpiramide, cefpiramide sodium or another explicitly identified form?","id":"explicit-material-form-q01","kind":"boundary"},{"text":"What counterion stoichiometry and water measurements justify its parent-equivalent mass conversion?","id":"explicit-material-form-q02","kind":"measurement"}]}]}]},{"id":"cefpiramide-quality","name":"Cefpiramide content and quality","description":"Determine how much intact cefpiramide a sample contains and which accompanying substances matter.","layers":[{"id":"assay-and-potency","name":"Assay and potency","description":"Keep chemical content and biological potency on explicit reference bases.","findings":[{"id":"traceable-content-basis","name":"Traceable content basis","description":"Each content or potency result must identify its method, standard and correction basis.","questions":[{"text":"What cefpiramide content was measured, and is it expressed on an as-received, dry or anhydrous basis?","id":"traceable-content-basis-q01","kind":"measurement"},{"text":"Which cefpiramide reference standard and assigned value support the assay or potency result?","id":"traceable-content-basis-q02","kind":"provenance"}]}]},{"id":"impurities-and-grade","name":"Impurities and grade","description":"Assess related substances and sample qualification against form-specific requirements.","findings":[{"id":"resolved-quality-profile","name":"Resolved quality profile","description":"Record impurity identities where established, unresolved analytical signals and the requirements governing the claimed grade.","questions":[{"text":"Which methods distinguish intact cefpiramide from its related substances, and what remains unidentified?","id":"resolved-quality-profile-q01","kind":"measurement"},{"text":"Which current specification supports accepting or rejecting this sample for its declared use?","id":"resolved-quality-profile-q02","kind":"action"}]}]}]},{"id":"cefpiramide-condition","name":"Cefpiramide physical condition and stability","description":"Relate physical properties and integrity to the material form and exposure conditions.","layers":[{"id":"physical-properties","name":"Physical properties","description":"Capture measured behaviour without assigning unsupported universal constants.","findings":[{"id":"conditioned-property-values","name":"Conditioned property values","description":"Attach material form and measurement conditions to solubility and thermal observations.","questions":[{"text":"What cefpiramide form, solvent, pH and temperature were used for each solubility measurement?","id":"conditioned-property-values-q01","kind":"measurement"},{"text":"Does the reported thermal event represent melting, desolvation or decomposition, and how was that established?","id":"conditioned-property-values-q02","kind":"measurement"}]}]},{"id":"integrity-over-time","name":"Integrity over time","description":"Assess changes after storage, dissolution or exposure.","findings":[{"id":"supported-stability-window","name":"Supported stability window","description":"A usable stability window requires a matching form, environment and analytical endpoint.","questions":[{"text":"What changes in cefpiramide content and impurity profile occur over the documented time, temperature, light and pH conditions?","id":"supported-stability-window-q01","kind":"measurement"},{"text":"After this sample's actual storage or preparation history, should it remain qualified, be retested or be quarantined?","id":"supported-stability-window-q02","kind":"action"}]}]}]},{"id":"cefpiramide-antibacterial-evidence","name":"Cefpiramide antibacterial evidence","description":"Represent experimentally supported antibacterial behaviour and its limits.","layers":[{"id":"activity-measurement","name":"Activity measurement","description":"Make activity observations comparable through their experimental context.","findings":[{"id":"target-specific-activity","name":"Target-specific activity","description":"Treat antibacterial activity as an observation tied to a test organism and protocol.","questions":[{"text":"What cefpiramide MIC or other antibacterial endpoint was measured for the identified isolate?","id":"target-specific-activity-q01","kind":"measurement"},{"text":"Which method, medium, inoculum, incubation conditions and controls produced that result?","id":"target-specific-activity-q02","kind":"provenance"}]}]},{"id":"mechanism-and-interpretation","name":"Mechanism and interpretation","description":"Separate direct cefpiramide evidence from class-level inference and clinical interpretation.","findings":[{"id":"limits-of-activity-inference","name":"Limits of activity inference","description":"Require specific support for resistance, target-binding and susceptibility interpretations.","questions":[{"text":"Which target-binding or resistance claims were demonstrated for cefpiramide itself rather than inferred from other cephalosporins?","id":"limits-of-activity-inference-q01","kind":"provenance"},{"text":"Does a current interpretive standard cover cefpiramide and this organism, or must the result remain an uninterpreted measurement?","id":"limits-of-activity-inference-q02","kind":"boundary"}]}]}]},{"id":"cefpiramide-handling-and-status","name":"Cefpiramide handling and status","description":"Connect material-specific safety evidence and regulatory records to permitted actions.","layers":[{"id":"handling-evidence","name":"Handling evidence","description":"Establish precautions from applicable cefpiramide documentation.","findings":[{"id":"material-specific-precautions","name":"Material-specific precautions","description":"Record documented hazard classifications, exposure controls and disposal requirements with their scope.","questions":[{"text":"Which current safety data sheet applies to this cefpiramide form and concentration, and what classifications does it report?","id":"material-specific-precautions-q01","kind":"provenance"},{"text":"What containment, protective equipment, spill response and waste route does that evidence require for the intended operation?","id":"material-specific-precautions-q02","kind":"action"}]}]},{"id":"jurisdiction-and-use","name":"Jurisdiction and use","description":"Identify which legal or compendial records govern a particular material and intended use.","findings":[{"id":"scoped-status-records","name":"Scoped status records","description":"Attach jurisdiction, effective date and regulated entity to each status claim.","questions":[{"text":"Which verified regulatory identifiers and current monographs apply specifically to cefpiramide or the supplied salt?","id":"scoped-status-records-q01","kind":"provenance"},{"text":"Does the cited status concern the substance, an active ingredient grade or a particular medicinal product?","id":"scoped-status-records-q02","kind":"boundary"}]}]}]},{"id":"evidence-and-external-alignment","name":"Evidence and external alignment","description":"What the world already says about this thing, gathered so the model can be checked against it.","layers":[{"id":"reported-evidence","name":"Reported evidence","description":"Findings from the breadth pass, kept separate from the structural claims.","findings":[{"id":"evidence-confidence-notes","name":"Check these first","description":"Recalled without web access and unsourced; every item is a lead to verify.","questions":[{"text":"Which of these check these first hold for the sense of cefpiramide this model covers, and on what evidence?","id":"evidence-confidence-notes-q01","kind":"provenance"}]},{"id":"evidence-identifiers","name":"Identifiers and schemes","description":"Recalled without web access and unsourced; every item is a lead to verify.","questions":[{"text":"Which of these identifiers and schemes hold for the sense of cefpiramide this model covers, and on what evidence?","id":"evidence-identifiers-q01","kind":"provenance"}]},{"id":"evidence-real-world-use","name":"Real-world use","description":"Recalled without web access and unsourced; every item is a lead to verify.","questions":[{"text":"Which of these real-world use hold for the sense of cefpiramide this model covers, and on what evidence?","id":"evidence-real-world-use-q01","kind":"provenance"}]},{"id":"evidence-failure-modes-and-hazards","name":"Failure modes and hazards","description":"Recalled without web access and unsourced; every item is a lead to verify.","questions":[{"text":"Which of these failure modes and hazards hold for the sense of cefpiramide this model covers, and on what evidence?","id":"evidence-failure-modes-and-hazards-q01","kind":"provenance"}]},{"id":"evidence-neighbours","name":"Neighbouring kinds and how to tell them apart","description":"Recalled without web access and unsourced; every item is a lead to verify.","questions":[{"text":"Which of these neighbouring kinds and how to tell them apart hold for the sense of cefpiramide this model covers, and on what evidence?","id":"evidence-neighbours-q01","kind":"provenance"}]}]}]}]},"agentConduct":{"may":["Describe cefpiramide's class, spectrum and clinical use from authoritative sources.","Note that availability differs by country."],"mustNot":["Recommend, dose or supply it to a person without a prescriber's decision.","Advise use without a confirmed bacterial infection.","Ignore a reported beta-lactam allergy.","Overlook clotting monitoring in patients at bleeding risk."],"requiresHuman":["Any decision to start, stop or change antibiotic treatment."]},"ethics":{"considerations":["Broad-spectrum antibiotics are a shared resource; overuse removes options for future patients."],"affectedParties":["Patients","Communities exposed to resistant bacteria","Prescribers"]},"owners":{"steward":"The marketing authorisation holder where it is licensed; the prescriber answers for each use.","roles":[],"masterSystems":["National medicines registers"]},"relations":[{"target":"Q11173","type":"parent","note":"registry parent class"}],"interaction":{"identity":{"applicability":"required","items":["Vercy registry: vr.tr.cefpiramide","Wikidata: Q4921174 (https://www.wikidata.org/wiki/Q4921174)"]},"properties":{"applicability":"required","items":["Parent substance identity: Reference structure, stereochemical representation and verified identifiers","Material form: Parent acid, specified salt, hydrate or solvate, solution, or unresolved form","Cefpiramide content: mg/g or mass %, with as-received, dry or anhydrous basis and method","Antibacterial potency: μg cefpiramide-equivalent potency per mg, with reference standard and assay protocol","Related substances: Individual and total impurity concentrations, identification confidence and detection limits","Water and residual solvents: Water mass %; named solvents in mg/kg; analytical method","Physical and solution condition: Phase, appearance, temperature, pH, solvent and concentration where applicable","Antibacterial susceptibility result: MIC in mg/L, with organism, isolate, method, medium, inoculum and date","Evidence-supported disposition: Untested, under review, qualified for a named use, quarantined or rejected","Applicable substance specification: Named monograph, supplier specification or jurisdictional record with version and material form"]},"recognition":{"applicability":"required","items":["A powder for injection; identity is confirmed by label and pharmacy records, not appearance."]},"capabilities":{"applicability":"required","items":["Resolve a cefpiramide label or identifier to a verified structure and explicit material form.","Compare a sample's identity, assay and impurity evidence against a specification appropriate to that form.","Calculate parent-equivalent content when counterion, water content and assay basis are established.","Assess whether recorded storage or preparation conditions fall within documented cefpiramide stability evidence.","Compare antibacterial results only after aligning assay conditions and biological targets.","Qualify or quarantine a sample for a named laboratory or supply-chain use according to documented criteria."]},"hazards":{"applicability":"required","items":["Allergic reactions.","Bleeding from reduced clotting factors.","Selection of resistant bacteria and gut infections."]},"interfaces":{"applicability":"required","items":["The Anatomical Therapeutic Chemical classification, maintained by the World Health Organization Collaborating Centre for Drug Statistics Methodology, classifies cefpiramide among third-generation cephalosporins."]},"context":{"applicability":"required","items":["Cefpiramide is encountered in pharmaceutical research, antibacterial susceptibility studies and medicinal products where authorized.","Analytical laboratories examine materials containing it to establish identity, composition and condition before interpreting their suitability for further use."]}},"sources":[{"title":"Wikidata item Q4921174: cefpiramide","url":"https://www.wikidata.org/wiki/Q4921174","note":"identity and sense of the item"},{"title":"Wikipedia: Cefpiramide","url":"https://en.wikipedia.org/wiki/Cefpiramide","note":"general description of the item"}],"openQuestions":["Does the existing Vercy catalogue already contain an authoritative cefpiramide model to which vr.tr.cefpiramide should link?","Which current compendial specifications and reference standards apply to parent cefpiramide versus cefpiramide sodium, including impurity identities and limits?","Which experimentally supported solubility, solid-state, thermal and stability measurements are available for each relevant material form?","Which current jurisdiction-specific safety classifications, exposure limits if any, and substance identifiers are verified?","Which cefpiramide-specific resistance studies and current susceptibility interpretive standards support activity judgments for particular organisms?"],"resources":{"spec":"/models/things/publications/thing-q4921174/spec.json"},"provenance":{"origin":"thing registry research (pass 2)","builtFrom":["models/things/publications/thing-q4921174/spec.json"],"providers":["Codex"],"researchStatus":"unreviewed","generatedAt":"2026-09-12T08:29:25Z","builder":"tools/build_cards.py@1.0.0"},"completeness":{"sections":{"classifiers":"filled","whatItIs":"filled","purpose":"filled","distinguishingFeatures":"filled","structure":"filled","agentConduct":"filled","ethics":"filled","owners":"filled","relations":"filled","interaction.identity":"filled","interaction.properties":"filled","interaction.recognition":"filled","interaction.capabilities":"filled","interaction.hazards":"filled","interaction.interfaces":"filled","interaction.context":"filled","sources":"filled"},"notes":{"_gate":"Published through the thing publication gate 1.0 on 2026-10-07T10:10:31+00:00: completeness 1.00; sense: Wikidata description; 2 live sources; review by codex: pass"},"score":1.0}}